versión impresa ISSN 1131-5768
The benign prostatic hyperplasia's clinic manifestations appear preferentially since 50 years of age. Differentiate symptomlogy according to its characteristics are "irritation" (dynamic component) or "obstruction" (static component) will direct the individual establishment to one or other farmacological treatment (alphablockers-hormone therapy). The clinic valuation and the quality of life, by the IPSS-L inquiry, the realization of the rectal touch and the quantifying of the PSA levels are necessary elements for the Primary Health Care doctor to decide if patient need to be treated in that place or should be derived. It´s proposed a consensuated action scheme as guide in this kind of patologies.
Palabras clave : Prostatic hyperplasia; Prostatic diseases.